Evaluation of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer

Evaluation of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer

Background/Aim: Triple negative breast cancer belongs to the most aggressive breast cancer forms. Histone deacetylases (HDACs) constitute a class of enzymes that exhibit a significant role in breast cancer genesis and progression. In this study, we aimed at assessing the clinical importance of HDAC-...

Full description

Bibliographic Details
Main Authors: Christos Damaskos, Iason Psilopatis, Anna Garmpi, Dimitrios Dimitroulis, Konstantinos Nikolettos, Kleio Vrettou, Panagiotis Sarantis, Evangelos Koustas, Gregory Kouraklis, Efstathios A. Antoniou, Michail V. Karamouzis, Nikolaos Nikolettos, Panagiotis Tsikouras, Georgios Marinos, Emmanouil Kontomanolis, Konstantinos Kontzoglou, Nikolaos Garmpis
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
triple
negative
breast
cancer
clinicopathological
histone
Online Access:https://www.mdpi.com/2072-6694/16/1/209

Internet

https://www.mdpi.com/2072-6694/16/1/209

Similar Items